Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Haematologica|February 24, 2018
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trialRiccardo Bomben, Simone Ferrero, Tiziana D'Agaro, et al.
Haematologica|March 24, 2018
Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemiaDaniela Drandi, Elisa Genuardi, Irene Dogliotti, et al.
Experimental Hematology|December 13, 2006
Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populationsMarco Ladetto, Barbara Mantoan, Federica De Marco, et al.
Blood|August 24, 2007
MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclastsSonia Vallet, Noopur Raje, Kenji Ishitsuka, et al.
British Journal of Haematology|January 21, 2021
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL)Carola Boccomini, Marco Ladetto, Luigi Rigacci, et al.
Leukemia|July 7, 2026
Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histologyJonas Lippl, Sarah Reinke, Karoline Koch, et al.
Blood Advances|March 22, 2021
Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trialsCarla Casulo, Jesse G Dixon, Fang-Shu Ou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2013
Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italiana LinfomiUmberto Vitolo, Marco Ladetto, Carola Boccomini, et al.
Haematologica|October 30, 2025
Marked survival gains in patients ≤ 65 years with advanced-stage mantle cell lymphoma: a pooled analysis of six randomized phase III trials, 1996-2020Linmiao Jiang, Marco Ladetto, Olivier Hermine, et al.
Leukemia & Lymphoma|July 9, 2019
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)Flavia Salvi, Stefano Luminari, Alessandra Tucci, et al.
Pageof 14